免疫系统中的DNA杂技

Intracellular Antibodies for Drug Discovery and as Drugs of the Future.

Antibodies (Basel, Switzerland)·2023

Selection of human single domain antibodies recognizing the CMYC protein using enhanced intracellular antibody capture.

Journal of immunological methods·2015

Conformational flexibility of the oncogenic protein LMO2 primes the formation of the multi-protein transcription complex.

Scientific reports·2014

Interfering with RAS-effector protein interactions prevent RAS-dependent tumour initiation and causes stop-start control of cancer growth.

Oncogene·2010

Microdissection molecular copy-number counting (microMCC)--unlocking cancer archives with digital PCR.

The Journal of pathology·2008

An antibody inhibitor of the LMO2-protein complex blocks its normal and tumorigenic functions.

Oncogene·2008

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Innate Immune Memory Responses in Organ Transplantation.

Arteriosclerosis, thrombosis, and vascular biology·2026

Complicated Jejunal Diverticulosis as a Rare Cause of Small Bowel Perforation in an Immunocompromised Patient: A Case Report.

Cureus·2026

10-HDA attenuates inflammatory responses in LPS-activated RAW264.7 cells <i>in vitro</i> via the NUR77/NF-κB pathways and improving mitochondrial functions.

Frontiers in pharmacology·2026

The IL-10-producing NKT10 subset plays a critical role in preventing graft-versus-host-disease.

Frontiers in immunology·2026

Life-threatening multiorgan immune-related toxicities complicated by sepsis after anti-PD-1 therapy with complete tumor regression: a case report and literature review.

Frontiers in immunology·2026

The multifaceted role of NF-κB signaling in psoriasis: from inflammatory amplification to epidermal remodeling.

Frontiers in immunology·2026

相关实验视频

免疫系统中的DNA杂技

相关概念视频

Intracellular Antibodies for Drug Discovery and as Drugs of the Future.

Selection of human single domain antibodies recognizing the CMYC protein using enhanced intracellular antibody capture.

Conformational flexibility of the oncogenic protein LMO2 primes the formation of the multi-protein transcription complex.

Interfering with RAS-effector protein interactions prevent RAS-dependent tumour initiation and causes stop-start control of cancer growth.

Microdissection molecular copy-number counting (microMCC)--unlocking cancer archives with digital PCR.

An antibody inhibitor of the LMO2-protein complex blocks its normal and tumorigenic functions.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Innate Immune Memory Responses in Organ Transplantation.

Complicated Jejunal Diverticulosis as a Rare Cause of Small Bowel Perforation in an Immunocompromised Patient: A Case Report.

10-HDA attenuates inflammatory responses in LPS-activated RAW264.7 cells <i>in vitro</i> via the NUR77/NF-κB pathways and improving mitochondrial functions.

The IL-10-producing NKT10 subset plays a critical role in preventing graft-versus-host-disease.

Life-threatening multiorgan immune-related toxicities complicated by sepsis after anti-PD-1 therapy with complete tumor regression: a case report and literature review.

The multifaceted role of NF-κB signaling in psoriasis: from inflammatory amplification to epidermal remodeling.

相关实验视频

免疫系统中的DNA杂技

相关概念视频

相关文章